Abstract
Faithful chromosome segregation requires that the sister chromatids be disjoined completely. Defective disjunction can lead to the persistence of histone-free threads of DNA known as ultra-fine bridges (UFBs) that connect the separating sister DNA molecules during anaphase. UFBs arise at specific genomic loci and can only be visualized by detection of associated proteins such as PICH, BLM, topoisomerase IIIα, and RPA. However, it remains unknown how these proteins work together to promote UFB processing. We used a combination of ensemble biochemistry and new single-molecule assays to reconstitute key steps of UFB recognition and processing by these human proteins in vitro. We discovered characteristic patterns of hierarchical recruitment and coordinated biochemical activities that were specific for DNA structures modeling UFBs arising at either centromeres or common fragile sites. Our results describe a mechanistic model for how unresolved DNA replication structures are processed by DNA-structure-specific binding factors in mitosis to prevent pathological chromosome nondisjunction.
Original language | English |
---|---|
Pages (from-to) | 868-876 |
Number of pages | 13 |
Journal | Nature Structural and Molecular Biology |
Volume | 25 |
Issue number | 9 |
Early online date | 3 Sept 2018 |
DOIs | |
Publication status | Published - Sept 2018 |
Funding
We thank G. King for helpful discussions, H. Mankouri for helpful comments on the manuscript, M. Nadal (Institut Jacques Monod) for the Sulfolobus solfactarius TopA, and M. Kanemaki (National Institute of Genetics, Japan) for development of the TopoIII protein degron system. Work in the authors’ laboratories is supported by the Danish National Research Fund (DNRF115), the European Union Horizon 2020 Programme ‘Chromavision’ (665233), the European Research Council, the Human Frontier Science Program, the Netherlands Organization for Scientific Research (NWO; ‘Catching PICH in the Act’ project number 741.015.002), the French National Research Agency, and the French National Cancer Institute.
Funders | Funder number |
---|---|
Danish National Research Fund | DNRF115 |
Netherlands Organization for Scientific Research | |
Human Frontier Science Program | |
Horizon 2020 Framework Programme | |
European Research Council | |
Agence Nationale de la Recherche | |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 741.015.002 |
Institut National Du Cancer | |
Horizon 2020 | 665233 |